Member Info for Chelsea11

Saying something along the lines of “positive outlook before the year end - trial results dependant” is classic Gypsy Petulengro, on Blackpool Pier.

😂

Cleaner - you must realise that a link to Genmab is only on the Scancell website, due to the commercial licensing agreement in place for the anti-GlyMab monoclonal antibody. Of course Scancell would want to put that collaboration up in lights but the point is, it tells us absolutely nothing new. Will you be cluttering up the BB with Trading Updates and Results for Pharmajet / Vaccitech / ISA Pharma too? (Please don’t or if you do, at least add some intelligence and contextual relevance). Without that it’s just a random copy & paste exercise, aka a Blat.

Nope. As usual, just an internet search engine blat.

Ruck.

Suggest you take a look down the back of the sofa. You might find your sense of humour there.

ATB.

Yes, old / recycled news.

Perhaps Ruck could pass it on to Fool 😂

Isn’t the overriding point something very different though? An investor (or car buyer) should be doing their own thorough due diligence from all available material and carefully weighing up risk v.reward in their own mind, whether looking to buy, or sell. If that investor chooses not to do that, or relies solely on an opinion of one internet article and it all goes belly up, they only have themselves to blame. Of course things could still go belly up here, that is the reality.

Am sure Lindy is still recovering from the devastating news that Fool haven’t tipped the Company 😂

A definite case of Decidophobia.

Alternative views, including who is telling the truth and who is lying to deliberately mislead others, are also available.

And not forgetting this one to………..

· 16th Annual PEGS Europe taking place in Barcelona, Spain and virtually from 5-7 November.

Mireille Vankemmelbeke, Principal Scientist, will be presenting.

Session Title: Antibody-Based Cancer Therapies: Novel Targets

Title: Fucosyl-GM1: A Versatile Target for SCLC Therapy

Date and Time: Tuesday, 5 November at 5.05pm CEST

Assume that there would be a lag between Scancell being given a thumbs up (if that’s the outcome of the evaluation) and formal notification to the Market.

May as well cast SCINV’s vote for him. He’ll say after and then call LD and her colleagues deliberate liars (along with multiple “I was right, listen to me, you’re all wrong etc etc”)

I now suspect after but perhaps not by much.

Aside from SCIB1 though, quite possible other news will arrive before year end.

Perhaps an alternative Bell trophy would be more appropriate.

Thanks for sharing your view Bob.

40 recruited to SCIB1 (was 36 in Results Presentation).

Agree there's unlikely to be any new information not already in the public domain. However it's an opportunity to suss out the "vibe" and ask probing questions. The answers to those, may provide some hints to what might come in the future. Open to individual interpretation of course.

Just lazy reporting imo Berm and doubt Scancell are bothered.

Lofas - what is definitely not impressive, are your SP predictions. 9p in September.